Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis in drug users

D C Perlman1, N Salomon, M P Perkins

  • 1Department of Medicine, Beth Israel Medical Center, New York, New York 10003, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of COVID-19: Lessons Unlearned from AIDS Denialism.

AIDS and behavior·2020
Same author

Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history.

Harm reduction journal·2019
Same author

Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.

The International journal on drug policy·2018
Same author

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.

PloS one·2018
Same author

HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis.

BMJ open·2015
Same author

Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City.

AIDS and behavior·2013
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Drug users face higher tuberculosis (TB) risks due to overlapping social and epidemiological factors. Targeted screening and treatment services are crucial for managing TB transmission in this vulnerable population.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) disproportionately affects specific populations, with a historical link to opiate addiction through therapeutic use.
  • Demographic shifts have redefined drug use as a significant risk factor for TB due to shared epidemiological and social factors.
  • The co-epidemic of human immunodeficiency virus (HIV) infection has further amplified TB transmission among drug users.

Purpose of the Study:

  • To review the epidemiology of TB in drug-using populations.
  • To identify challenges and factors relevant to screening, prevention, diagnosis, and treatment compliance in drug users.
  • To highlight the potential of tailored TB services in disrupting TB transmission chains.

Main Methods:

  • Literature review of epidemiological studies on TB in drug users.

Related Experiment Videos

  • Analysis of factors influencing screening and treatment adherence.
  • Examination of the intersection of TB, drug use, and HIV.

    • Main Results:

    • Drug users represent a high-risk group for TB with unique challenges in healthcare engagement.
    • Screening, infection prevention, diagnosis, and treatment present specific hurdles in this population.
    • Effective TB services engaging drug users, both in and out of treatment programs, are vital.

    Conclusions:

    • Addressing TB in drug users requires specialized approaches due to heightened risks and complex needs.
    • Engaging drug users in TB services can significantly disrupt transmission dynamics.
    • Integrated strategies are essential for controlling TB in populations with substance use disorders.